A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, highlighting RTN4IP1 and ECHS1 as uncharacterized regulators with potential implications for mitochondrial diseases. Here, RTN4IP1 is linked to inborn mitochondrial metabolism disorder.